IMARC Group has recently released a new research study titled “Canada Artificial Intelligence in Healthcare Market Size, Share, Trends and Forecast by Offering, Technology, Application, End User and Region, 2025-2033,” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Canada Artificial Intelligence in Healthcare Market Overview
The Canada artificial intelligence in healthcare market size reached USD 163.80 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,321.44 Million by 2033, exhibiting a growth rate (CAGR) of 36.81% during 2025-2033.
Market Size and Growth
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 163.80 Million
Market Forecast in 2033: USD 3,321.44 Million
Market Growth Rate 2025-2033: 36.81%
Request for a sample copy of the report: https://www.imarcgroup.com/canada-artificial-intelligence-in-healthcare-market/requestsample
Key Market Highlights:
✔️ Rapid digital transformation across healthcare systems is accelerating AI adoption for diagnostics, treatment planning, and patient monitoring
✔️ Increasing government and private investments are supporting AI-driven medical innovations and research
✔️ Growing integration of machine learning in medical imaging, virtual care, and hospital workflow automation is improving clinical outcomes and operational efficiency
Canada Artificial Intelligence in Healthcare Market Trends
The Canada artificial intelligence in healthcare market is moving through a period of major change, shaped by new regulations and rising use of digital health solutions. The Artificial Intelligence and Data Act (AIDA) introduced stricter standards, while growing privacy concerns in 2024 pushed Health Canada to accelerate approvals for AI-driven diagnostic tools. These changes helped drive a 40% year-over-year increase in AI-assisted medical imaging, underscoring how regulation and innovation are working in tandem to influence Canada artificial intelligence in healthcare market growth.
Provincial Investments and Rising Demand
Provincial programs are adding momentum. Ontario’s $120 million AI Health Fund has strengthened collaboration between startups and hospital networks, while demand for AI-powered remote patient monitoring has jumped by 55% since 2024. This growth reflects both Canada’s aging population and an ongoing shortage of physicians. However, inconsistent data-sharing policies between provinces continue to limit large-scale adoption, pushing hospitals toward hybrid cloud solutions. At the same time, ethical issues—such as algorithmic bias in Indigenous healthcare—remain a central topic in shaping the future of the market.
A key driver of Canada artificial intelligence in healthcare market growth is precision oncology. In 2024, AI-based genomic tools represented 32% of the market, supported by national projects like the Pan-Canadian Genome Library, which uses federated learning to study more than 500,000 patient genomes while protecting privacy. Pharmaceutical companies, including Roche, invested over $200 million in AI drug discovery initiatives, with a strong focus on rare diseases.
Surgical robotics is also gaining ground. Advances in computer vision and haptic feedback reduced cardiac intervention errors by 60% and cut recovery times by nearly one-third in 2024. These developments are reinforcing confidence in AI adoption, particularly within surgical and hospital operations. Beyond clinical uses, AI is improving workflow efficiency by optimizing billing, scheduling, and even assisting nurses with voice-enabled documentation—saving the healthcare system an estimated $380 million annually.
Despite these gains, challenges remain. Rising supply chain costs and global chip shortages have increased robotics prices, limiting adoption in smaller hospitals. Cybersecurity risks are also pressing, with high-profile breaches in Quebec highlighting vulnerabilities in AI-driven healthcare systems. In addition, Canada continues to face a shortage of domestic AI talent, with nearly 75% of developers relocating to the U.S., which is slowing innovation.
Emerging Canada Artificial Intelligence in Healthcare Market Trends
Recent trends highlight a shift from diagnostics to predictive care. AI is now being applied to forecast ICU bed shortages and predict complications in chronic conditions such as diabetes. Alberta’s $90 million investment in AI ethics research underscores the growing importance of responsible innovation. Cloud-based AI adoption rose by 48% in 2024, reflecting hospitals’ need for scalable solutions, especially as delays in robotic deployments continue. Increasing alignment with U.S. and EU regulatory frameworks is also opening new opportunities for Canadian healthcare AI exports, although cross-border compliance and data sovereignty remain critical concerns.
Canada Artificial Intelligence in Healthcare Market Outlook
Looking ahead, the Canada artificial intelligence in healthcare market outlook points to steady expansion through 2025 and beyond. Growth will be supported by decentralized clinical trials for rare diseases, Indigenous-led data governance, and stronger oversight of algorithmic fairness. While workforce shortages, cybersecurity risks, and cost barriers remain challenges, collaboration between government, healthcare providers, and industry leaders is expected to strengthen Canada’s position in this space. With rising Canada artificial intelligence in healthcare market demand, expanding investments, and a supportive regulatory environment, the sector is poised for sustained growth and innovation.
Canada Artificial Intelligence in Healthcare Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Breakup by Offering:
-
Hardware
-
Software
-
Services
Breakup by Technology:
-
Machine Learning
-
Context Aware Computing
-
Natural Language Processing
-
Others
Breakup by Application:
-
Robot-Assisted Surgery
-
Virtual Nursing Assistant
-
Administrative Workflow Assistance
-
Fraud Detection
-
Dosage Error Reduction
-
Clinical Trial Participant Identifier
-
Preliminary Diagnosis
-
Others
Breakup by End User:
-
Healthcare Providers
-
Pharmaceutical and Biotechnology Companies
-
Patients
-
Others
Breakup by Region:
-
Ontario
-
Quebec
-
Alberta
-
British Columbia
-
Others
Ask Analyst & Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=28900&flag=C
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Key Highlights of the Report
1. Market Performance (2019-2024)
2. Market Outlook (2025-2033)
3. COVID-19 Impact on the Market
4. Porter’s Five Forces Analysis
5. Strategic Recommendations
6. Historical, Current and Future Market Trends
7. Market Drivers and Success Factors
8. SWOT Analysis
9. Structure of the Market
10. Value Chain Analysis
11. Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91-120-433-0800
United States: +1 201971-6302
Comments
0 comment